Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery
Launched by JENA UNIVERSITY HOSPITAL · Mar 29, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
A high proportion of patients experience moderate to severe pain after surgery. However, most of the knowledge about this comes from studies where patients are evaluated in the hours and up until the first postoperative day. Alternatively, patients are assessed several months (eg 3 or later) after surgery, to evaluate the development of chronic pain related to surgery (CPSP) and most patients do not develop CPSP.
This study aims to learn how patients recover concerning pain and function once they return home after surgery. How long is it before they can resume their daily activities and to...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult
- • 2. On the first post-operative day and back on the ward for at least 6 hours
- • 3. Gives consent for assessment at 3-time points
- Exclusion Criteria:
- • 1. The patient is unable to communicate
- • 2. The patient is cognitively impaired
- • 3. The patient is asleep
- • 4. The patient is too ill or in too much pain and does not wish to be interviewed
- • 5. The patient does not wish to fill in the outcomes questionnaire
About Jena University Hospital
Jena University Hospital is a leading academic medical center located in Jena, Germany, renowned for its commitment to advancing healthcare through innovative research and high-quality clinical care. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous studies aimed at evaluating new treatments, medical devices, and healthcare interventions. With a strong focus on collaboration between clinicians, researchers, and academic partners, Jena University Hospital plays a pivotal role in translating scientific discoveries into tangible benefits for patients, ultimately enhancing the quality of medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jena, , Germany
Mexico City, , Mexico
Mexico City, Cdmx, Mexico
El Bajo, Chihuahua, Mexico
León, Guanajuato, Mexico
Guadalajara, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Mexico City, , Mexico
Puebla, , Mexico
San Luis Potosi, , Mexico
Patients applied
Trial Officials
Ana L Garduño López, MD
Principal Investigator
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Vicotor M Acosta-Nava, MD
Principal Investigator
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Ruth Zaslansky, DSc
Principal Investigator
Jena University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials